相关实验视频
Updated: May 5, 2026
06:14
In vitro Biofilm Formation in an 8-well Chamber Slide
Published on: January 20, 2011
40.2K
生物膜生产及其对儿科的影响
Nicola Principi1, Susanna Esposito2
1Università degli Studi di Milano, 20122 Milan, Italy.
Microorganisms
|August 29, 2024
概括
细菌生物膜通过抵抗抗生素导致持续的儿科呼吸道感染. 新的抗生素膜策略显示出希望,但需要临床试验才能有效治疗儿童疾病.
科学领域:
- 儿科呼吸系统医学 儿科呼吸系统医学
- 微生物学 微生物学
- 传染性疾病 传染性疾病
背景情况:
- 细菌生物膜有助于持续的儿科呼吸道感染,如中耳炎和囊性纤维化恶化.
- 这些生物膜,即自我生成的基质中的细菌聚合物,与儿童时期的复发性和慢性疾病有关.
- 生物膜显著降低了抗生素的有效性,导致治疗失败和持续性感染.
研究的目的:
- 通过关键儿科呼吸道病原体审查生物膜的产生.
- 检查生物膜形成机制,抗生素耐药性和临床治疗挑战.
- 讨论新兴的抗菌膜策略及其临床翻译障碍.
主要方法:
- 这是一个对现有文学作品的叙述性回顾.
- 它合成了关于儿童呼吸道感染中的生物膜产生病原体的信息.
- 它评估了当前和潜在的抗菌膜治疗策略.
主要成果:
- 常见的儿科呼吸道病原体,如 * 肺炎杆菌 * * 流感血球 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 * * 肺炎杆菌 *
- 生物膜的形成赋予了显著的抗生素耐药性,使治疗复杂化.
- 实验性抗菌膜策略 (例如,N-乙半氨酸,B分散素,定数感应抑制剂) 显示出潜力,但缺乏临床验证.
- 新型抗菌膜策略在儿童的临床应用目前是有限的.
结论:
- 儿童呼吸道感染的有效管理需要解决细菌生物膜的问题.
- 将有希望的体外和动物研究结果转化为临床实践至关重要.
- 需要进一步的研究,包括强大的临床试验和标准化检测方法,以克服与生物膜相关的儿童治疗挑战.
相关概念视频
01:24What are Membranes?
14.6K
A cell's plasma membrane demarcates the cell's borders and determines the nature of its interaction with the environment. Cells exclude certain substances, take in others, and excrete some others in controlled quantities. The plasma membrane must be flexible to allow certain cells, such as red and white blood cells, to change their shape while passing through narrow capillaries. These are the more obvious plasma membrane functions. In addition, the plasma membrane's surface carries...
14.6K
01:07Teratogenicity
4.2K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.2K
01:22Development of Immunocompetence
1.2K
The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
01:30Development of Human Microbiota
68
The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
68
01:28Development of the Oral Microbiota
73
The establishment of the oral microbiome begins before birth, challenging the long-held belief that the fetal oral cavity is sterile. The presence of oral microbes such as Streptococcus and Fusobacterium in amniotic fluid suggests that microbial exposure may occur in utero, potentially through translocation from the maternal oral or gastrointestinal tract. This early colonization primes the neonatal immune system and sets the stage for subsequent microbial succession. Maternal health,...
73